FLT3 and acute myeloid leukemia: Our results are in contrast to those obtained with midostaurin in AML where inhibition of autophosphorylation of mutated Flt-3 was documented in leukaemic blasts isolated from patients receiving midostaurin (Stone et al, 2005).